磁共振兼容起搏器的临床应用
|
摘要
目的分析本中心磁共振兼容起搏器的临床应用情况和磁共振检查的安全性。方法对2016年11月至2018年10月在贵州省人民医院心内科植入磁共振兼容起搏器的83例患者进行随访,观察磁共振检查对磁共振兼容起搏器参数的影响。结果其中有1例患者因病情需要进行了磁共振检查,检查部位为颈椎及腰椎,检查过程中无不良事件发生,检查前后起搏参数无显著变化。结论磁共振兼容起搏器可安全地完成MRI检查。
Objective To analyze the clinical application of magnetic resonance imaging(MRI) compatible pacemarker and the safety of MRI on the pacemarker from our center. Methods Eighty three patients with MRI compatible pacemakers implanted in our hospital were followed up from November in 2016 to October in 2018. The patients were observed the changes of MRI compatible pacemarker after MRI. Results One of the patients underwent MRI because of the need of the disease. The site of the examination was cervical vertebra and lumbar vertebrae. No adverse events occurred during the examination, and there was no significant change in pacing parameters before and after the examination. Conclusion MRI is safe for the patients with MRI compatible pacemarker according to our center's experience.
Objective To analyze the clinical application of magnetic resonance imaging(MRI) compatible pacemarker and the safety of MRI on the pacemarker from our center. Methods Eighty three patients with MRI compatible pacemakers implanted in our hospital were followed up from November in 2016 to October in 2018. The patients were observed the changes of MRI compatible pacemarker after MRI. Results One of the patients underwent MRI because of the need of the disease. The site of the examination was cervical vertebra and lumbar vertebrae. No adverse events occurred during the examination, and there was no significant change in pacing parameters before and after the examination. Conclusion MRI is safe for the patients with MRI compatible pacemarker according to our center's experience.
引文
[1] G?tte MJ,Rüssel IK,de Roest GJ,et al.Magnetic resonance imaging,pacemakers and implantable cardioverter-defibrillators:current situation and clinical perspective[J].Neth Heart J,2010,18(1):31-37.
[2] 植入性心脏起搏器治疗:目前认识和建议(2010年修订版)[J].中国继续医学教育,2011,(11):40-54.
[3] 徐强,屈百鸣.心脏起搏器和转复除颤器植入后的磁共振检查—从绝对禁忌证到允许有条件检查[J].中国心脏起搏与心电生理杂志,2009,23(3):250-254.
[4] Chow GV,Nazarian S.MRI for patients with cardiac implantable electrical devices[J].Cardiol Clin,2014,32(2):299-304.
[5] Maglia G,Curnis A,Brieda M,et al.Really ProMRI Stuady Group.ssessing access to MRI of patients with magnetic resonance-conditional pacemaker and implantable cardioverter defibrillator systems:the Really ProMRI study design[J].J Cardiovasc Med(Hagerstown),2015,16(10):715-720.
[6] Nazarian S,Hansford R,Rahsepar,et al.Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices[J].N Engl J Med,2017,377(26):2555-2564.
[7] Gimbel JR,Kanal E.Can patients with implantable pacemakers safely undergo magnetic resonace imaging?[J].J Am Coil Cardiol,2004,43(7):l 325-7.
[8] Imich W,Irnich B,Bartseh C,et a1.Do we need pacemakers resistant to magnetic resonance imaging[J].Europace,2005,7(4):353-65.
[9] Wilkoff BL,Bello D,Taborsky M,et al.Magnetic resonance imaging in patients with a pacem aker system designed for the magnetic resonance environment[J].Heart R hythm,2011,8(1):65-73.
[10] Jung W,Zvereva V,Hajredini B,et al.Safe magnetic resonance image scanning of the pacemaker patient:current technologies and future directions[J].Europace,2012,14(5):631-617.
[11] Mollerus M,Albin G,Lipinski M,et al.Magnetic resonance imaging of pacemakersand implantable cardioverter-defibrillators without specific absorption rate.estrictions[J].Europace,2010,12(7):947-951.
[12] Bailey WM,Rosenthal L,Fananapazir L,et al.Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions[J].Heart rhythm,2015,12(6):1183-1191.
[13] Bailey WM,Mazur A,McCotter C,et al.Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions[J].Heart Rhythm,2016,13(2):464-471.
[14] Gimbel JR,Bello D,Schmitt M,et al.Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla[J].Heart Rhythm,2013,10(5):685-691.
[15] Brignole M,Auricchio A,Baron-Esquivias G,et al.2013 ESC Guidelines oncardiac pacing and cardiac resynchronization therapy:the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology(ESC)[J].Eur Heart J,2013,34(29):2281-2329.
[16] 陈学颖,柏瑾,等.磁共振兼容心脏起搏器的单中心植入现状分析[J].中华心律失常学杂志,2017,21(2):268-270.
[17] 廖予斌,吴立荣,李羚,等.参松养心胶囊对植入埋藏式起搏器患者的疗效观察[J].贵州医药,2016,40(6):618-619.
[18] 周本军.永久性心脏起搏器植入术167例临床分析[J].贵州医药,2012,36(10):894-895.
[19] 吴冬燕,卢凤民,李琼,等.2017磁共振兼容起搏器的临床应用评价[J].中华心率失常杂志,2017,21(2):103-104.
[2] 植入性心脏起搏器治疗:目前认识和建议(2010年修订版)[J].中国继续医学教育,2011,(11):40-54.
[3] 徐强,屈百鸣.心脏起搏器和转复除颤器植入后的磁共振检查—从绝对禁忌证到允许有条件检查[J].中国心脏起搏与心电生理杂志,2009,23(3):250-254.
[4] Chow GV,Nazarian S.MRI for patients with cardiac implantable electrical devices[J].Cardiol Clin,2014,32(2):299-304.
[5] Maglia G,Curnis A,Brieda M,et al.Really ProMRI Stuady Group.ssessing access to MRI of patients with magnetic resonance-conditional pacemaker and implantable cardioverter defibrillator systems:the Really ProMRI study design[J].J Cardiovasc Med(Hagerstown),2015,16(10):715-720.
[6] Nazarian S,Hansford R,Rahsepar,et al.Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices[J].N Engl J Med,2017,377(26):2555-2564.
[7] Gimbel JR,Kanal E.Can patients with implantable pacemakers safely undergo magnetic resonace imaging?[J].J Am Coil Cardiol,2004,43(7):l 325-7.
[8] Imich W,Irnich B,Bartseh C,et a1.Do we need pacemakers resistant to magnetic resonance imaging[J].Europace,2005,7(4):353-65.
[9] Wilkoff BL,Bello D,Taborsky M,et al.Magnetic resonance imaging in patients with a pacem aker system designed for the magnetic resonance environment[J].Heart R hythm,2011,8(1):65-73.
[10] Jung W,Zvereva V,Hajredini B,et al.Safe magnetic resonance image scanning of the pacemaker patient:current technologies and future directions[J].Europace,2012,14(5):631-617.
[11] Mollerus M,Albin G,Lipinski M,et al.Magnetic resonance imaging of pacemakersand implantable cardioverter-defibrillators without specific absorption rate.estrictions[J].Europace,2010,12(7):947-951.
[12] Bailey WM,Rosenthal L,Fananapazir L,et al.Clinical safety of the ProMRI pacemaker system in patients subjected to head and lower lumbar 1.5-T magnetic resonance imaging scanning conditions[J].Heart rhythm,2015,12(6):1183-1191.
[13] Bailey WM,Mazur A,McCotter C,et al.Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions[J].Heart Rhythm,2016,13(2):464-471.
[14] Gimbel JR,Bello D,Schmitt M,et al.Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla[J].Heart Rhythm,2013,10(5):685-691.
[15] Brignole M,Auricchio A,Baron-Esquivias G,et al.2013 ESC Guidelines oncardiac pacing and cardiac resynchronization therapy:the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology(ESC)[J].Eur Heart J,2013,34(29):2281-2329.
[16] 陈学颖,柏瑾,等.磁共振兼容心脏起搏器的单中心植入现状分析[J].中华心律失常学杂志,2017,21(2):268-270.
[17] 廖予斌,吴立荣,李羚,等.参松养心胶囊对植入埋藏式起搏器患者的疗效观察[J].贵州医药,2016,40(6):618-619.
[18] 周本军.永久性心脏起搏器植入术167例临床分析[J].贵州医药,2012,36(10):894-895.
[19] 吴冬燕,卢凤民,李琼,等.2017磁共振兼容起搏器的临床应用评价[J].中华心率失常杂志,2017,21(2):103-104.